Labelling Compliance for Medical Devices: Wanted Global Harmonisation!
Peter Schroeer, Director Europe, Quality Systems & Regulatory Affairs at Johnson & Johnson, speaks to Andrea Charles from Pharma IQ, about the current compliance challenges the medical device market faces and what impact the reuse warning statement requirement per directive 2007/47/EC has had on global labeling strategies. He also shares his top 3 tips for defining and implementing a global labeling strategy and his insights on what future global...
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.